Question 1

Does Bank of Nova Scotia own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Bank of Nova Scotia holds 181,706 shares of REGN (Regeneron Pharmaceuticals), worth $113.3M.

Question 2

How many shares of REGN does Bank of Nova Scotia own?

Accepted Answer

As of its Q2 2026 13F, Bank of Nova Scotia holds 181,706 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is Bank of Nova Scotia's REGN position worth?

Accepted Answer

As of its Q2 2026 13F, Bank of Nova Scotia's REGN position is worth $113.3M.

Question 4

Is Bank of Nova Scotia buying or selling REGN?

Accepted Answer

In Q2 2026, Bank of Nova Scotia increased its REGN position by 84,186 shares (+86.3%).

Question 5

When did Bank of Nova Scotia first buy REGN?

Accepted Answer

Bank of Nova Scotia already held REGN in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	181,706	+86.3%	$113.3M	0.2%	$622.81	56
2026-Q1	Decreased	97,520	-18.7%	$75.3M	0.1%	$770.59	0
2025-Q4	Decreased	120,011	-56.9%	$92.6M	0.1%	$768.90	0
2025-Q3	Increased	278,551	+11.7%	$156.6M	0.3%	$559.40	41
2025-Q2	Increased	249,278	+103.3%	$130.9M	0.3%	$521.53	58
2025-Q1	Increased	122,589	+36.0%	$77.7M	0.2%	$629.11	46
2024-Q4	Decreased	90,162	-8.6%	$64.2M	0.1%	$705.67	0
2024-Q3	Increased	98,691	+2.7%	$103.7M	0.2%	$1,041.41	37